rs3831003

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1

The NM_004999.4(MYO6):​c.1546+7_1546+8delGT variant causes a splice region, intron change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0101 in 1,604,278 control chromosomes in the GnomAD database, including 746 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.013 ( 72 hom., cov: 32)
Exomes 𝑓: 0.0098 ( 674 hom. )

Consequence

MYO6
NM_004999.4 splice_region, intron

Scores

Not classified

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 7.38

Publications

1 publications found
Variant links:
Genes affected
MYO6 (HGNC:7605): (myosin VI) This gene encodes a reverse-direction motor protein that moves toward the minus end of actin filaments and plays a role in intracellular vesicle and organelle transport. The protein consists of a motor domain containing an ATP- and an actin-binding site and a globular tail which interacts with other proteins. This protein maintains the structural integrity of inner ear hair cells and mutations in this gene cause non-syndromic autosomal dominant and recessive hearing loss. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
MYO6 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 22
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD, AR Classification: DEFINITIVE, MODERATE Submitted by: ClinGen, G2P
  • autosomal recessive nonsyndromic hearing loss 37
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hearing loss, autosomal recessive
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP6
Variant 6-75861098-ATG-A is Benign according to our data. Variant chr6-75861098-ATG-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 45137.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.137 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO6NM_004999.4 linkc.1546+7_1546+8delGT splice_region_variant, intron_variant Intron 15 of 34 ENST00000369977.8 NP_004990.3 Q9UM54-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO6ENST00000369977.8 linkc.1546+4_1546+5delTG splice_region_variant, intron_variant Intron 15 of 34 1 NM_004999.4 ENSP00000358994.3 Q9UM54-1

Frequencies

GnomAD3 genomes
AF:
0.0131
AC:
1987
AN:
152162
Hom.:
71
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000338
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0129
Gnomad ASJ
AF:
0.00749
Gnomad EAS
AF:
0.145
Gnomad SAS
AF:
0.0207
Gnomad FIN
AF:
0.0695
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00200
Gnomad OTH
AF:
0.0115
GnomAD2 exomes
AF:
0.0256
AC:
6432
AN:
251104
AF XY:
0.0244
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.0329
Gnomad ASJ exome
AF:
0.00764
Gnomad EAS exome
AF:
0.153
Gnomad FIN exome
AF:
0.0648
Gnomad NFE exome
AF:
0.00292
Gnomad OTH exome
AF:
0.0162
GnomAD4 exome
AF:
0.00981
AC:
14251
AN:
1451998
Hom.:
674
AF XY:
0.00991
AC XY:
7161
AN XY:
722942
show subpopulations
African (AFR)
AF:
0.000180
AC:
6
AN:
33280
American (AMR)
AF:
0.0298
AC:
1331
AN:
44678
Ashkenazi Jewish (ASJ)
AF:
0.00649
AC:
169
AN:
26058
East Asian (EAS)
AF:
0.152
AC:
5984
AN:
39438
South Asian (SAS)
AF:
0.0175
AC:
1506
AN:
86018
European-Finnish (FIN)
AF:
0.0609
AC:
3237
AN:
53186
Middle Eastern (MID)
AF:
0.00174
AC:
10
AN:
5746
European-Non Finnish (NFE)
AF:
0.00108
AC:
1197
AN:
1103534
Other (OTH)
AF:
0.0135
AC:
811
AN:
60060
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
652
1304
1957
2609
3261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
164
328
492
656
820
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0131
AC:
1988
AN:
152280
Hom.:
72
Cov.:
32
AF XY:
0.0165
AC XY:
1230
AN XY:
74454
show subpopulations
African (AFR)
AF:
0.000337
AC:
14
AN:
41584
American (AMR)
AF:
0.0130
AC:
199
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00749
AC:
26
AN:
3472
East Asian (EAS)
AF:
0.146
AC:
754
AN:
5180
South Asian (SAS)
AF:
0.0205
AC:
99
AN:
4824
European-Finnish (FIN)
AF:
0.0695
AC:
736
AN:
10586
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00200
AC:
136
AN:
68026
Other (OTH)
AF:
0.0113
AC:
24
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
90
180
270
360
450
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00702
Hom.:
5
Bravo
AF:
0.0100
Asia WGS
AF:
0.0720
AC:
247
AN:
3468

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 14, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

1546+7_1546+8del in intron 15 of MYO6: This variant is not expected to have clin ical significance because it has been identified in 16% (93/572) of Asian chromo somes by 1000 Genomes Project (dbSNP rs138200430). -

Nonsyndromic Hearing Loss, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hearing loss, autosomal recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 37;C2931767:Autosomal dominant nonsyndromic hearing loss 22 Benign:1
Jul 30, 2021
Fulgent Genetics, Fulgent Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
7.4
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3831003; hg19: chr6-76570815; COSMIC: COSV107477131; COSMIC: COSV107477131; API